Researchers Report That Thymosin Beta 4 Improves Neurological Function After Stroke

 08.03.2010 08:15   medicalnewstoday.com

RegeneRx Biopharmaceuticals, Inc. (NYSE Alternext US:RGN) announced that a research team from the Henry Ford Hospital in Detroit, MI reported that Thymosin beta 4 (Tβ4), administered to rats one day after embolic stroke, improved neurological functional outcome compared to control animals...

World Neurology

University Of Chicago And Ataxia Foundation Team Up For Annual Scientific And Patient Meetings

The National Ataxia Foundation (NAF), in conjunction with the University of Chicago program in patho...

Ritalin Boosts Learning By Increasing Brain Plasticity

Doctors treat millions of children with Ritalin every year to improve their ability to focus on task...

Clues To The Role Of Brain Plaques Typical In Alzheimer's Patients

A study from EPFL's (Ecole Polytechnique Federale de Lausanne) Laboratory of Neuroenergetics and Cel...

Evidence-Based Treatment For Childhood Epilepsy

The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizu...

Students' Physical Fitness Associated With Academic Achievement; Organized Physical Activity Linked To Lower Body Fat In Girls

Physical fitness is associated with academic performance in young people, according to a report pres...

Novel MRI Sensor Provides Molecular View Of The Brain

MIT neuroscientists have designed a new MRI sensor that responds to the neurotransmitter dopamine, a...

Test Of Implantable Cardioverter Defibrillator Linked To Cognitive Problems

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought...

Latest Advances In Minimally Invasive Medicine Featured At Society Of Interventional Radiology Meeting March 13-18 In Tampa, Fla.

The Society of Interventional Radiology (SIR) will present the latest research on treatments for ind...

Reconstruction Of 3-D Hand Movement Using Brain Signals Suggests Future Portable Prosthetic Devices For The Movement-Impaired

Researchers have successfully reconstructed 3-D hand motions from brain signals recorded in a no...

LDN Phase II Trial Results Published - Multiple Sclerosis Society

Results of a phase II clinical trial on the safety and effectiveness of low dose naltrexone (LDN) as...